Osteonecrosis of the head of femur in a Nigerian teaching hospital

Authors

  • L. O. Thanni
  • S. A. Gbadegesin
  • A. A. Adebanjo
  • B. A. Osundina
  • B. F. Olushiyan

Keywords:

Osteonecrosis, avascular necrosis, head of femur, sickle cell disease, risk factors

Abstract

Objective: Osteonecrosis (ON) of the head of femur is not uncommon. The characteristics of affected patients and the associated aetiological factors in Nigeria are largely undocumented. To determine the epidemiological characteristics of patients with osteonecrosis of the head of femur, the radiological severity at presentation and associated aetiological risk factors

Methods: A retrospective study was done, of patients with femoral head ON seen between January 2013 and January 2019. Data on patients' characteristics, affected hips and radiological severity were entered onto a proforma and analysed.

Results: There were 29 patients with ON of the head of femur involving 32 hips. There were 55.2% females and 44.8% male patients. While 3 (10.3%) patients had bilateral affectation, 26 (89.7%) had unilateral affectation. Their mean age is 26.6years ± 13.3. The mean age of male and female patients are 29.3 years and 24.3 years respectively. The mean BMI is 21.9 ± 5.2 and no significant difference in the BMI of both genders, p=0.74. Ninety percent of them presented with advanced radiographic stages. Factors found to be associated with ON are sickle cell disease (SCD) 44.8%, trauma 13.8%, CVA 3.4% and idiopathic cases 37.7%. There is no significant difference in the frequency of unilateral and bilateral occurrence in the groups with different hemoglobin genotypes.

Conclusions: Osteonecrosis of the head of femur occurs more often in young patients. They present late, with collapse of the head of femur. SCD, especially HbSS is the most common associated risk factor followed by idiopathic cases.

References

Hernigou P, Daltro G, Hernigou J.

Hiposteonecrosis: stem cells for life or behead and arthroplasty? Int Orthop 2018; 42:1425 – 1428

Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFFORT Open Rev 2019; 4(3): 85 – 97

Gun BK, Frank RM, Gratton RW, Bader JO, Kusnezov N, Orr JD, et al. Non modifiable risk factors associated with avascular necrosis in the US military. Mil Med 2019; jun 11. Pii. Usz128. doi: 10.1093/milmed/usz128 [Epub ahead of print]

Daltro G, Franco BA, Faleiro TB, Rosario DAV, Daltro PB, Fortuna V. Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a crosssectional study. Int Orthop 2018; 42(7):1527 – 1534

Kaushik AP, Das A, Cui Q. Osteonecrosis of the femoral head: An update in year 2012. World J

Orthop 2012; 3(5): 49 – 57

Osawa Y, Seki T, Tagegami Y, Kasai T, Higuchi Y, Ishiguro N. Do femoral head collapse and the contralateral condition affect patient-reported quality of life and referral pain in patients with osteonecrosis of the femoral head. Int Orthop 2018; 42: 1463 – 1468

Matos MA, SiLva LLDS, Alves GB, de Alcantara WS, Velga D. Necrosis of the femoral head and health related quality of life of children and adolescents. Acta Ortop Bras 2018; 26(4): 227 – 230

Adelowo OO, Oguntona S. Avascular necrosis of femoral head associated with connective tissue disease in Nigerians: case series. West Afr J Med 2009; 28: 262 – 265

Akinyoola AL, Adediran IA, Asaleye CM,

Bolarinwa AR. Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease. Int Orthop 2009; 33: 923 – 926

Akinyoola AL, Adediran IA, Asaleye CM.

Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J 2007; 14: 217 – 220

Lamb JN, Holton C, O'Connor P, Giannoudis PV. Avascular necrosis of the hip. BMJ 2019; 365: 12178

Vardhan H, Tripathy SK, Sen RK, Aggarwal S, Goyal T. Epidemiological profile of femoral head osteonecrosis in the North Indian population. Indian J Orthop 2019; 52: 140 – 146

Kubo T, Ueshima K, Salto M, Ishida M, Aral Y, Fujiwara H. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan. J Orthop Sci 2016; 21: 407 413

Adesina O, Brunson A, Keegan THM, Wun T. Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities and surgical outcomes in California. Blood Adv 2017; 1(16): 1287 – 1295

Iwegbu CG, Fleming AF. Avascular necrosis of the femoral head in sickle-cell disease. A series from the Guinea Savannah of Nigeria. J Bone joint Surg Br 1985; 67(1): 29 – 32

Akinyanju OO. A profile of sickle cell disease in Nigeria. Ann NY Acad Sci 1989; 565: 126 – 136

Emechebe GO, Onyire NB, Orji ML, Achigbu KI. Sickle cell disease in Nigeria-A review. IOSR Journal of Dental and Medical Sciences 2017; 16(1): 87 – 94

Sung PH, Yang YH, Chianh HJ, Chiang JY, Chen CJ, Yip HK, Lee MS. Cardiovascular and cerebrovascular events are associated with nontraumatic osteonecrosis of the femoral head. Clin Orthop Relat Res 2018; 476(4): 865 – 874

Downloads

Published

2023-10-08

How to Cite

Thanni, L. O., Gbadegesin, S. A., Adebanjo, A. A., Osundina, B. A., & Olushiyan, B. F. (2023). Osteonecrosis of the head of femur in a Nigerian teaching hospital. Research Journal of Health Sciences, 8(1), 18–24. Retrieved from https://rjhs.org/index.php/home/article/view/233